Comments
Sun Pharmaceutical has entered into a licence agreement with US-based Pharmazz Inc to commercialise Tyvalzi (Sovateltide), in India.
Developed by Pharmazz, Sovateltide is indicated for treating cerebral ischemic stroke. Sun Pharma has been granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide) and Pharmazz will be entitled to upfront and milestone payments, including royalties, a note from Sun Pharma said.
Kirti Ganorkar, Sun Pharma’s Chief Executive (India Business), said, “The Phase 3 clinical trial for Tyvalzi conducted in India demonstrated statistically and clinically meaningful improvement in neurological outcomes in ischemic stroke. Tyvalzi is a first-in-class innovative drug that can help improve the quality of life of stroke patients. The drug can be administered within 24 hours for the treatment of ischemic stroke. The current treatment options provide a narrow time window of 4-5 hours limiting its use in most patients.”
New therapies
BS Paul, a neuro-physician at Ludhiana’s Dayanand Medical College & Hospital, who was a part of the clinical trials on the drug, added that there was a need for new therapies to treat stroke, the second leading cause of mortality and morbidity worldwide. In India, studies estimate the incidence of stroke to vary from 116 to 163 per 100,000 population, the note said.
Pharmazz is a privately held company that develops novel products in critical care medicine. It obtained marketing authorization for two of its first-in-class drug molecules, Centhaquine and Sovateltide, for hypovolemic shock and ischemic stroke, respectively, in India.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.